News | April 27, 2026
Sun Pharma to acquire Organon in $11.75 billion all-cash deal
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
_256_384.png){kind=logo}
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
The deal signals a clear push to expand access to care in underserved regions
The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Subscribe To Our Newsletter & Stay Updated
